These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27630302)

  • 1. Mutation Screening of Her-2, N-ras and Nf1 Genes in Brain Tumor Biopsies.
    Yapijakis C; Adamopoulou M; Tasiouka K; Voumvourakis C; Stranjalis G
    Anticancer Res; 2016 Sep; 36(9):4607-11. PubMed ID: 27630302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
    Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I
    Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia.
    Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T
    Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
    Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation screening of neurofibromatosis type 1 (NF1) exons 28 and 29 with single strand conformation polymorphism (SSCP): five novel mutations, one recurrent transition and two polymorphisms in a panel of 118 unrelated NF1 patients. Mutations in brief no. 229. Online.
    Peters H; Lüder A; Harder A; Schuelke M; Tinschert S
    Hum Mutat; 1999; 13(3):258. PubMed ID: 10090487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic p53 mutations and absence of ras mutations in glioblastomas.
    Gömöri E; Dóczi T; Pajor L; Matolcsy A
    Acta Neurochir (Wien); 1999; 141(6):593-9. PubMed ID: 10929724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
    Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.
    Scheurlen WG; Senf L
    Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and ras mutations in Ewing's sarcoma.
    Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
    Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
    Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
    Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
    Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
    Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
    Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
    Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent involvement of mutations on neurofibromatosis type 1, H-ras, K-ras and N-ras in urothelial tumors.
    Uchida T; Wada C; Ishida H; Egawa S; Ao T; Yokoyama E; Koshiba K
    Urol Int; 1995; 55(2):63-7. PubMed ID: 8533197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas.
    Knobbe CB; Reifenberger J; Reifenberger G
    Acta Neuropathol; 2004 Dec; 108(6):467-70. PubMed ID: 15517309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.